Should I buy or sell Fresenius Medical Care stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares. View FMS analyst ratings or view top-rated stocks .

What is Fresenius Medical Care's stock price target for 2024?

8 equities research analysts have issued 1 year price targets for Fresenius Medical Care's stock. Their FMS share price targets range from $24.00 to $24.00. On average, they expect the company's stock price to reach $24.00 in the next twelve months. This suggests a possible upside of 23.8% from the stock's current price. View analysts price targets for FMS or view top-rated stocks among Wall Street analysts .

How have FMS shares performed in 2024?

Fresenius Medical Care's stock was trading at $20.83 at the beginning of 2024. Since then, FMS shares have decreased by 6.9% and is now trading at $19.39. View the best growth stocks for 2024 here .

Are investors shorting Fresenius Medical Care?

Fresenius Medical Care saw a decrease in short interest in March. As of March 31st, there was short interest totaling 1,100,000 shares, a decrease of 17.3% from the March 15th total of 1,330,000 shares. Based on an average trading volume of 441,200 shares, the days-to-cover ratio is currently 2.5 days. View Fresenius Medical Care's Short Interest .

When is Fresenius Medical Care's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024. View our FMS earnings forecast .

How were Fresenius Medical Care's earnings last quarter?

Fresenius Medical Care AG (NYSE:FMS) posted its quarterly earnings results on Tuesday, February, 20th. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.11. The firm earned $5.37 billion during the quarter, compared to analyst estimates of $5.32 billion. Fresenius Medical Care had a trailing twelve-month return on equity of 4.99% and a net margin of 2.56%.

How often does Fresenius Medical Care pay dividends? What is the dividend yield for Fresenius Medical Care?

Fresenius Medical Care announced an annual dividend on Monday, April 15th. Shareholders of record on Monday, May 20th will be paid a dividend of $0.437 per share on Monday, June 3rd. This represents a dividend yield of 2.35%. The ex-dividend date of this dividend is Friday, May 17th. Read our dividend analysis for FMS .

Is Fresenius Medical Care a good dividend stock?

Fresenius Medical Care (NYSE:FMS) pays an annual dividend of $0.42 per share and currently has a dividend yield of 2.23%. The dividend payout ratio is 45.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 21.54% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for FMS .

What ETF holds Fresenius Medical Care's stock?

Cultivar ETF holds 16,385 shares of FMS stock, representing 1.04% of its portfolio.

What other stocks do shareholders of Fresenius Medical Care own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care investors own include Energy Transfer (ET) , Petra Diamonds (PDL) , AT&T (T) , Pfizer (PFE) , AbbVie (ABBV) , Gilead Sciences (GILD) , Merck & Co., Inc. (MRK) , Abbott Laboratories (ABT) , Chevron (CVX) and Ford Motor (F) .

Who are Fresenius Medical Care's major shareholders?

Fresenius Medical Care's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Partnership Wealth Management LLC (0.02%) and GAMMA Investing LLC (0.00%).

How do I buy shares of Fresenius Medical Care?

Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

Does Fresenius Medical Care have any subsidiaries?

The following companies are subsidiares of Fresenius Medical Care: NxStage Medical. Read More

NYSE:FMS

Fresenius Medical Care (FMS) Stock Price, News & Analysis

→ Biden’s $374B Giveaway Into This Sector (From DTI) (Ad)

Free FMS Stock Alerts

$19.39

+0.42 (+2.21%)

(As of 04/18/2024 ET)

Compare

Today's Range: $19.03
▼
$19.41
50-Day Range: $18.39
▼
$21.22
52-Week Range: $16.37
▼
$27.72

Volume: 625,142 shs
Average Volume: 431,009 shs
Market Capitalization: $11.38 billion

P/E Ratio: 21.08
Dividend Yield: 2.17%
Price Target: $24.00

Get Fresenius Medical Care alerts:

Fresenius Medical Care MarketRank™ Stock Analysis

Analyst Rating: Hold
2.13 Rating Score
Upside/Downside: 23.8% Upside
$24.00 Price Target
Short Interest: Healthy
0.19% of Shares Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.73
Based on 6 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 27.45%
From $1.53 to $1.95 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.28 out of 5 stars

Medical Sector

126th out of 918 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

3rd out of 6 stocks

2.1

Analyst's Opinion

Consensus Rating
Fresenius Medical Care has received a consensus rating of Hold. The company's average rating score is 2.13, and is based on 2 buy ratings, 5 hold ratings, and 1 sell rating.
Amount of Analyst Coverage
Fresenius Medical Care has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
0.19% of the outstanding shares of Fresenius Medical Care have been sold short.
Short Interest Ratio / Days to Cover
Fresenius Medical Care has a short interest ratio ("days to cover") of 2.5, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in Fresenius Medical Care has recently decreased by 17.29%, indicating that investor sentiment is improving significantly.

2.5

Dividend Strength

Dividend Yield
Fresenius Medical Care pays a meaningful dividend of 2.23%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Fresenius Medical Care does not have a long track record of dividend growth.
Dividend Coverage
The dividend payout ratio of Fresenius Medical Care is 45.65%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Fresenius Medical Care will have a dividend payout ratio of 21.54% next year. This indicates that Fresenius Medical Care will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for FMS.

3.2

News and Social Media Coverage

News Sentiment
Fresenius Medical Care has a news sentiment score of 0.73. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 6 news articles for Fresenius Medical Care this week, compared to 2 articles on an average week.
Search Interest
Only 2 people have searched for FMS on MarketBeat in the last 30 days. This is a decrease of -33% compared to the previous 30 days.
MarketBeat Follows
5 people have added Fresenius Medical Care to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Fresenius Medical Care insiders have not sold or bought any company stock.
Percentage Held by Institutions
Only 8.25% of the stock of Fresenius Medical Care is held by institutions.

5.0

Earnings and Valuation

Earnings Growth
Earnings for Fresenius Medical Care are expected to grow by 27.45% in the coming year, from $1.53 to $1.95 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Fresenius Medical Care is 21.08, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 142.54.
Price to Earnings Ratio vs. Sector
The P/E ratio of Fresenius Medical Care is 21.08, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 231.05.
Price to Earnings Growth Ratio
Fresenius Medical Care has a PEG Ratio of 0.90. PEG Ratios below 1 indicate that a company could be undervalued.
Price to Book Value per Share Ratio
Fresenius Medical Care has a P/B Ratio of 0.71. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Fresenius Medical Care Stock (NYSE:FMS)

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, and physician nephrology and cardiology services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

FMS Stock Price History

30 days | 90 days | 365 days | Advanced Chart

FMS Stock News Headlines

April 17, 2024 | americanbankingnews.com

Fresenius Medical Care (NYSE:FMS) Upgraded to "Strong-Buy" by StockNews.com

April 13, 2024 | americanbankingnews.com

Comparing Global Cord Blood (NYSE:CORBF) and Fresenius Medical Care (NYSE:FMS)

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

April 9, 2024 | americanbankingnews.com

Fresenius Medical Care AG (NYSE:FMS) Given Consensus Rating of "Hold" by Analysts

March 22, 2024 | prnewswire.com

Fresenius Medical Care publishes 2023 joint Annual Report and Sustainability Report: Shaping the Future of Kidney Care

March 19, 2024 | prnewswire.com

Fresenius Medical Care launches "Augmented Reality" for training on Kidney Replacement Therapy device

March 17, 2024 | finance.yahoo.com

FMS Oct 2024 20.000 call

March 17, 2024 | finance.yahoo.com

FMS Jul 2024 17.500 call

April 18, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

March 13, 2024 | prnewswire.com

Fresenius Medical Care appoints Jörg Häring as new Management Board member responsible for Legal, Compliance and Human Resources

March 9, 2024 | finance.yahoo.com

Fresenius Medical Care (ETR:FME) Will Pay A Larger Dividend Than Last Year At €1.19

March 5, 2024 | finance.yahoo.com

Why Dialysis Stocks Are Up This Morning

March 5, 2024 | prnewswire.com

Fresenius Medical Care Achieves Next Milestone in Portfolio Optimization Program, Announcing Sale of Dialysis Clinics in Brazil, Colombia, Chile, Ecuador

March 5, 2024 | msn.com

Novo Nordisk slips, dialysis stocks gain after kidney disease data for Ozempic

February 23, 2024 | seekingalpha.com

Broyhill - Fresenius Medical Care: Correctly Focused On Increasing Margins And Returns

February 23, 2024 | seekingalpha.com

Fresenius Medical Care AG (FMS) Q4 2023 Earnings Call Transcript

February 22, 2024 | finance.yahoo.com

A Look At The Fair Value Of Fresenius Medical Care AG (ETR:FME)

February 21, 2024 | msn.com

A New Cause for Concern: Fresenius Medical Care Adds a New International Operations Risk

February 21, 2024 | finance.yahoo.com

Fresenius Medical (FMS) Q4 Earnings Beat, Operating Margin Up

February 21, 2024 | finance.yahoo.com

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) Q4 2023 Earnings Call Transcript

February 20, 2024 | msn.com

Dialysis Player Fresenius Medical's Q4 Sales Hold Steady: Details

February 20, 2024 | seekingalpha.com

Fresenius Medical Care AG 2023 Q4 - Results - Earnings Call Presentation

February 20, 2024 | prnewswire.com

Fresenius Medical Care delivers on commitments in a year of fundamental transformation

February 17, 2024 | finance.yahoo.com

What Makes Fresenius Medical Care AG (FMS) an Investment Bet?

February 15, 2024 | morningstar.com

Fresenius Medical Care AG ADR FMS

February 5, 2024 | finance.yahoo.com

Fresenius Medical Care AG nominates Six Employee Representatives to the Supervisory Board

January 9, 2024 | finance.yahoo.com

Fresenius Medical (FMS) Divests Businesses to Optimize Portfolio

See More Headlines

Receive FMS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Fresenius Medical Care and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 2/20/2024
Today: 4/18/2024
Next Earnings (Estimated): 5/14/2024
Ex-Dividend for 6/3 Dividend: 5/17/2024
Dividend Payable: 6/03/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Medical
Industry: Miscellaneous health & allied services, not elsewhere classified
Sub-Industry: N/A
Current Symbol: NYSE:FMS
CUSIP: N/A
CIK: 1333141
Web: www.freseniusmedicalcare.com
Phone: (496) 172-6090
Fax: 49-6172-609-2301
Employees: 1,358
Year Founded: 1912

Price Target and Rating

Average Stock Price Target: $24.00
High Stock Price Target: $24.00
Low Stock Price Target: $24.00
Potential Upside/Downside: +23.8%
Consensus Rating: Hold
Rating Score (0-4): 2.13
Research Coverage: 8 Analysts

Profitability

EPS (Most Recent Fiscal Year): $0.92
Trailing P/E Ratio: 21.07
Forward P/E Ratio: 12.67
P/E Growth: 0.9
Net Income: $540.07 million
Net Margins: 2.56%
Pretax Margin: 5.31%
Return on Equity: 4.99%
Return on Assets: 2.15%

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 1.42
Quick Ratio: 1.07

Sales & Book Value

Annual Sales: $21.05 billion
Price / Sales: 0.54
Cash Flow: $4.82 per share
Price / Cash Flow: 4.02
Book Value: $27.34 per share
Price / Book: 0.71

Miscellaneous

Outstanding Shares: 586,830,000
Free Float: N/A
Market Cap: $11.37 billion
Optionable: Optionable
Beta: 1.00

Social Links

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Ms. Helen Giza (Age 56)
CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG
Comp: $5.25M
Mr. Martin Fischer (Age 47)
CFO & Member of the Management Board of Fresenius Medical Care Management AG
Comp: $944.42k
Dr. Franklin W. Maddux F.A.C.P. (Age 67)
Global Chief Medical Officer & Member of Management Board of Fresenius Medical Care Management AG
Comp: $2.95M
Dr. Katarzyna Mazur-Hofsab Ph.D. (Age 61)
Management Board Member for Care Enablement of Fresenius Medical Care Management AG
Comp: $3.07M
Mr. Craig Cordola FACHE (Age 54)
M.B.A., M.H.A., CEO of Care Delivery & Member of Management Board
Dr. Dominik Heger
Executive VP and Head of Investor Relations, Strategic Development & Communications
Mr. Joachim Weith
Senior Vice President of Corporate Communications & Governmental Affairs
Dr. Gail-Suzanne Brown
Senior Vice President of Research & Development
Mr. Glenn Slater
Senior Vice President of Manufacturing and Supply Chain Operations
Dr. Wolfgang Kummerle
Senior Vice President - Quality Management International

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

FMS Stock Analysis - Frequently Asked Questions

Should I buy or sell Fresenius Medical Care stock right now?: 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Fresenius Medical Care in the last twelve months. There are currently 1 sell rating, 5 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" FMS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in FMS, but not buy additional shares or sell existing shares.
View FMS analyst ratings or view top-rated stocks.
What is Fresenius Medical Care's stock price target for 2024?: 8 equities research analysts have issued 1 year price targets for Fresenius Medical Care's stock. Their FMS share price targets range from $24.00 to $24.00. On average, they expect the company's stock price to reach $24.00 in the next twelve months. This suggests a possible upside of 23.8% from the stock's current price.
View analysts price targets for FMS or view top-rated stocks among Wall Street analysts.
How have FMS shares performed in 2024?: Fresenius Medical Care's stock was trading at $20.83 at the beginning of 2024. Since then, FMS shares have decreased by 6.9% and is now trading at $19.39.
View the best growth stocks for 2024 here.
Are investors shorting Fresenius Medical Care?: Fresenius Medical Care saw a decrease in short interest in March. As of March 31st, there was short interest totaling 1,100,000 shares, a decrease of 17.3% from the March 15th total of 1,330,000 shares. Based on an average trading volume of 441,200 shares, the days-to-cover ratio is currently 2.5 days.
View Fresenius Medical Care's Short Interest.
When is Fresenius Medical Care's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Tuesday, May 14th 2024.
View our FMS earnings forecast.
How were Fresenius Medical Care's earnings last quarter?: Fresenius Medical Care AG (NYSE:FMS) posted its quarterly earnings results on Tuesday, February, 20th. The company reported $0.47 earnings per share for the quarter, beating the consensus estimate of $0.36 by $0.11. The firm earned $5.37 billion during the quarter, compared to analyst estimates of $5.32 billion. Fresenius Medical Care had a trailing twelve-month return on equity of 4.99% and a net margin of 2.56%.
How often does Fresenius Medical Care pay dividends? What is the dividend yield for Fresenius Medical Care?: Fresenius Medical Care announced an annual dividend on Monday, April 15th. Shareholders of record on Monday, May 20th will be paid a dividend of $0.437 per share on Monday, June 3rd. This represents a dividend yield of 2.35%. The ex-dividend date of this dividend is Friday, May 17th.
Read our dividend analysis for FMS.

Is Fresenius Medical Care a good dividend stock?: Fresenius Medical Care (NYSE:FMS) pays an annual dividend of $0.42 per share and currently has a dividend yield of 2.23%. The dividend payout ratio is 45.65%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, FMS will have a dividend payout ratio of 21.54% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for FMS.
What ETF holds Fresenius Medical Care's stock?: Cultivar ETF holds 16,385 shares of FMS stock, representing 1.04% of its portfolio.
What other stocks do shareholders of Fresenius Medical Care own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Fresenius Medical Care investors own include Energy Transfer (ET), Petra Diamonds (PDL), AT&T (T), Pfizer (PFE), AbbVie (ABBV), Gilead Sciences (GILD), Merck & Co., Inc. (MRK), Abbott Laboratories (ABT), Chevron (CVX) and Ford Motor (F).
Who are Fresenius Medical Care's major shareholders?: Fresenius Medical Care's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Partnership Wealth Management LLC (0.02%) and GAMMA Investing LLC (0.00%).
How do I buy shares of Fresenius Medical Care?: Shares of FMS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.
Does Fresenius Medical Care have any subsidiaries?: The following companies are subsidiares of Fresenius Medical Care: NxStage Medical.
Read More

This page (NYSE:FMS) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Fresenius Medical Care (FMS) Stock Price, News & Analysis

Fresenius Medical Care MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Fresenius Medical Care Stock (NYSE:FMS)

FMS Stock Price History

FMS Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Social Links

Key Executives

Key Competitors

Institutional Ownership

FMS Stock Analysis - Frequently Asked Questions

Overall MarketRank^™